Long‐Term Survival, Burden of Disease, and Patient‐Centered Outcomes in Maximally Treated Intracerebral Hemorrhage

Anne Mrochen(Friedrich-Alexander-Universität Erlangen-Nürnberg), Jochen A. Sembill(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stefan T. Gerner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Maximilian I. Sprügel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Joji B. Kuramatsu(RoMed Kliniken), Stefanie Balk(Friedrich-Alexander-Universität Erlangen-Nürnberg), David Haupenthal(Friedrich-Alexander-Universität Erlangen-Nürnberg), Stefan Schwab(Friedrich-Alexander-Universität Erlangen-Nürnberg), Kosmas Macha(Universitätsklinikum Erlangen), Hannes Lücking(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alexander Sekita(Universitätsklinikum Erlangen), Arnd Doerfler(Universitätsklinikum Erlangen)
Annals of Clinical and Translational Neurology
April 14, 2025
10.1002/acn3.70048
Cited by 2

Related Papers

Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
|The Lancet|2019|524
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
|The Lancet|2020|190
Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage
|JAMA|2019|183
Association of prothrombin complex concentrate administration and hematoma enlargement in non–vitamin <scp>K</scp> antagonist oral anticoagulant–related intracerebral hemorrhage
|Annals of Neurology|2018|134
Fatal Encephalitis Associated with Borna Disease Virus 1
|New England Journal of Medicine|2018|133